BSE Live
Dec 24, 16:01Prev. Close
5593.95
Open Price
5575.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 24, 15:57Prev. Close
5597.00
Open Price
5570.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Alkem Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 6,534.80 | 5,631.36 | 5,196.70 | 4,603.04 | 3,897.10 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 6,534.80 | 5,631.36 | 5,196.70 | 4,603.04 | 3,897.10 | |
| Total Operating Revenues | 6,677.08 | 5,714.09 | 5,300.26 | 4,668.45 | 3,951.04 | |
| Other Income | 95.98 | 67.58 | 81.66 | 116.60 | 251.28 | |
| Total Revenue | 6,773.06 | 5,781.67 | 5,381.92 | 4,785.05 | 4,202.32 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 1,799.87 | 1,497.22 | 1,327.69 | 1,232.26 | 969.42 | |
| Purchase Of Stock-In Trade | 784.38 | 688.09 | 838.95 | 775.04 | 611.94 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -33.69 | 86.56 | -91.42 | -211.92 | -34.06 | |
| Employee Benefit Expenses | 1,066.76 | 960.09 | 861.63 | 722.25 | 626.63 | |
| Finance Costs | 38.71 | 28.26 | 32.37 | 23.68 | 58.67 | |
| Depreciation And Amortisation Expenses | 186.84 | 141.07 | 107.65 | 76.48 | 73.53 | |
| Other Expenses | 1,592.11 | 1,436.42 | 1,370.76 | 1,272.83 | 1,057.34 | |
| Total Expenses | 5,434.98 | 4,837.71 | 4,447.63 | 3,890.62 | 3,363.47 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1,338.08 | 943.96 | 934.29 | 894.43 | 838.85 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 1,338.08 | 943.96 | 934.29 | 894.43 | 838.85 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 278.33 | 200.41 | 201.66 | 190.94 | 161.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -173.29 | -56.29 | 16.79 | -179.67 | -22.34 | |
| Tax For Earlier Years | -31.38 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 73.66 | 144.12 | 218.45 | 11.27 | 138.66 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1,264.42 | 799.84 | 715.84 | 883.16 | 700.19 | |
| Profit/Loss From Continuing Operations | 1,264.42 | 799.84 | 715.84 | 883.16 | 700.19 | |
| Profit/Loss For The Period | 1,264.42 | 799.84 | 715.84 | 883.16 | 700.19 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 105.75 | 66.90 | 59.87 | 73.86 | 58.56 | |
| Diluted EPS (Rs.) | 105.75 | 66.90 | 59.87 | 73.86 | 58.56 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 358.70 | 179.35 | 179.35 | 71.74 | 151.85 | |
| Tax On Dividend | 73.21 | 36.46 | 36.51 | 14.60 | 30.90 | |
| Equity Dividend Rate (%) | 1,250.00 | 800.00 | 650.00 | 750.00 | 635.00 |
04.12.2025
Alkem Lab Consolidated September 2025 Net Sales at Rs 4,000.99 crore, up 17.17% Y-o-Y
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key